| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4707 | 2018 |
| The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ... Cell reports 23 (1), 313-326. e5, 2018 | 873 | 2018 |
| Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy Y Min, KC Roche, S Tian, MJ Eblan, KP McKinnon, JM Caster, S Chai, ... Nature nanotechnology 12 (9), 877-882, 2017 | 621 | 2017 |
| Integrated molecular characterization of testicular germ cell tumors H Shen, J Shih, DP Hollern, L Wang, R Bowlby, SK Tickoo, V Thorsson, ... Cell reports 23 (11), 3392-3406, 2018 | 382 | 2018 |
| Perspective on oncogenic processes at the end of the beginning of cancer genomics L Ding, MH Bailey, E Porta-Pardo, V Thorsson, A Colaprico, D Bertrand, ... Cell 173 (2), 305-320. e10, 2018 | 378 | 2018 |
| B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer DP Hollern, N Xu, A Thennavan, C Glodowski, S Garcia-Recio, KR Mott, ... Cell 179 (5), 1191-1206. e21, 2019 | 369 | 2019 |
| Current landscape of immunotherapy in breast cancer: a review S Adams, ME Gatti-Mays, K Kalinsky, LA Korde, E Sharon, ... JAMA oncology 5 (8), 1205-1214, 2019 | 345 | 2019 |
| Genomic analysis of immune cell infiltrates across 11 tumor types MD Iglesia, JS Parker, KA Hoadley, JS Serody, CM Perou, BG Vincent Journal of the National Cancer Institute 108 (11), djw144, 2016 | 337 | 2016 |
| Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma PJ Siska, KE Beckermann, FM Mason, G Andrejeva, AR Greenplate, ... JCI insight 2 (12), 2017 | 320 | 2017 |
| Alternative tumour-specific antigens CC Smith, SR Selitsky, S Chai, PM Armistead, BG Vincent, JS Serody Nature Reviews Cancer 19 (8), 465-478, 2019 | 300 | 2019 |
| Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer MD Iglesia, BG Vincent, JS Parker, KA Hoadley, LA Carey, CM Perou, ... Clinical Cancer Research 20 (14), 3818-3829, 2014 | 291 | 2014 |
| Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers OMT Pearce, RM Delaine-Smith, E Maniati, S Nichols, J Wang, S Böhm, ... Cancer discovery 8 (3), 304-319, 2018 | 289 | 2018 |
| Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma CC Smith, KE Beckermann, DS Bortone, AA De Cubas, LM Bixby, SJ Lee, ... The Journal of clinical investigation 128 (11), 4804-4820, 2019 | 253 | 2019 |
| Systematic analysis of splice-site-creating mutations in cancer RG Jayasinghe, S Cao, Q Gao, MC Wendl, NS Vo, SM Reynolds, Y Zhao, ... Cell reports 23 (1), 270-281. e3, 2018 | 229 | 2018 |
| Claudin-low bladder tumors are immune infiltrated and actively immune suppressed J Kardos, S Chai, LE Mose, SR Selitsky, B Krishnan, R Saito, MD Iglesia, ... JCI insight 1 (3), 2016 | 219 | 2016 |
| A strong B-cell response is part of the immune landscape in human high-grade serous ovarian metastases A Montfort, O Pearce, E Maniati, BG Vincent, L Bixby, S Böhm, T Dowe, ... Clinical Cancer Research 23 (1), 250-262, 2017 | 192 | 2017 |
| The transcription factor Bhlhe40 programs mitochondrial regulation of resident CD8+ T cell fitness and functionality C Li, B Zhu, YM Son, Z Wang, L Jiang, M Xiang, Z Ye, KE Beckermann, ... Immunity 51 (3), 491-507. e7, 2019 | 191 | 2019 |
| Interleukin-23 engineering improves CAR T cell function in solid tumors X Ma, P Shou, C Smith, Y Chen, H Du, C Sun, N Porterfield Kren, ... Nature biotechnology 38 (4), 448-459, 2020 | 186 | 2020 |
| A dual immunotherapy nanoparticle improves T‐cell activation and cancer immunotherapy Y Mi, CC Smith, F Yang, Y Qi, KC Roche, JS Serody, BG Vincent, ... Advanced Materials 30 (25), 1706098, 2018 | 179 | 2018 |
| Emerging nano‐/microapproaches for cancer immunotherapy Y Mi, CT Hagan IV, BG Vincent, AZ Wang Advanced Science 6 (6), 1801847, 2019 | 159 | 2019 |
